SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending after a short-seller released a report alleging substantial financial overstatements and undisclosed related-party transactions, raising serious questions about the company's accounting practices. This has sparked intense community debate over its fundamental health, market manipulation, and the credibility of analyst ratings, with many drawing parallels to past major fraud accusations.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending amid significant investor frustration, with recent analyst downgrades fueling accusations of market manipulation to suppress its price. Despite solid fundamentals, including strong cash flow and aggressive share buybacks, the stock continues to hit multi-year lows, leading many to believe it's unjustifiably undervalued. The community keenly awaits upcoming earnings for a potential catalyst, while the stock significantly lags a broader market hitting all-time highs.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is heavily trending as investors anticipate its upcoming earnings report, with community sentiment sharply divided and many expressing extreme frustration over the stock's recent price action. Despite a history of strong financial performance and expectations for another beat, shareholders are vocal about perceived market manipulation and the impact of a recent stock offering, while long-term holders view current levels as a significant buying opportunity ahead of potential S&P 500 inclusion and future growth.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is soaring to new all-time highs, driven by growing concerns over dollar debasement, inflation fears, and escalating geopolitical tensions, which many in the community view as a critical hedge against systemic financial risks. This rapid ascent has ignited a fierce debate, with bulls anticipating further parabolic gains from central bank accumulation, while bears warn of an unsustainable 'mania' ripe for a significant correction.

Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe. The company was founded on June 5, 2025 and is headquartered in George Town, Cayman Islands.

Namib Minerals.

Namib Minerals

Namib Minerals (NAMM) is trending amidst soaring gold prices reaching all-time highs, igniting strong community interest. Discussions frequently revolve around a potential short squeeze, with many anticipating substantial price appreciation and actively watching for key resistance levels to break, driven by the stock's low float and high cost-to-borrow for shorts.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as the market grapples with the Federal Reserve's decision to hold interest rates, with many community members labeling the outcome and Jerome Powell's press conference a "nothing burger" due to limited immediate price movement. This has led to frustration among options traders, as participants now keenly await upcoming big tech earnings for the next significant market catalyst amidst mixed signals on economic strength and inflation.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is generating buzz following news of a substantial federal financing package and private placement, both aimed at strengthening the domestic rare earth supply chain. While this government backing is viewed as strategically critical for U.S. independence in minerals, community discussion reveals mixed sentiment, with concerns over significant share dilution battling long-term optimism for the company's future growth. Many are debating whether current volatility is a result of market manipulation or a temporary digestion phase before a larger upward trend.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is generating significant buzz ahead of its anticipated earnings report, with investors sharply divided on whether the company's aggressive AI infrastructure spending will drive strong returns or disappoint. The community is actively debating the impact of these substantial investments and the potential for a volatile market reaction. This report is keenly watched as a key indicator for the broader tech sector, especially concerning AI development and capital expenditures.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is capturing significant market attention due to widespread anticipation of a major NASA Lunar Terrain Vehicle (LTV) contract award, sparking vibrant community discussions about its potential announcement. The company's confirmed role in tracking the upcoming Artemis II mission further builds credibility, with many participants speculating on breakout potential and short squeeze opportunities within the expanding space sector.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending after announcing a $75 million registered direct offering to a single institutional investor, intended to fund preparations for its upcoming Phase 3 MASH trial, which triggered significant pre-market volatility. The community is sharply divided, with some viewing the financing as a strategic de-risking move that bolsters confidence in the company's best-in-class pemvidutide, while others express frustration over dilution and a perceived lack of immediate partnership. Despite initial share price reactions, optimists highlight the institutional backing and a recent analyst $20 price target as validation for Altimmune's potential in the high-value MASH market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE

Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group...

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit...

SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud...

Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026...

SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage...

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE Skye Bioscience, Inc. Securities Fraud Class...

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK...

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm PR Newswire NEW YORK, Jan. 6, 2026 NEW YORK...

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience...

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.30	-$0.24	19.22%	BEAT
Q3 '25	-$0.31	-$0.32	-1.99%	MISSED
Q2 '25	-$0.31	-$0.44	-41.51%	MISSED
Q1 '25	-$0.29	-$0.28	2.42%	BEAT
Q4 '24	-$0.28	-$0.24	13.80%	BEAT

SKYE
Skye Bioscience Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SKYE News

SKYESkye Bioscience Inc